Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An antiaggregation gene therapy strategy for Lewy body disease utilizing β-synuclein lentivirus in a transgenic model

14 Oct 2004

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autism Spectrum Disorder Research
Share to Nuclear Receptors and Signaling
Share to Parkinson's Disease Mechanisms and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 15483670
DOI: 10.1038/sj.gt.3302349

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An antiaggregation gene therapy strategy for Lewy body disease utilizing β-synuclein lentivirus in a transgenic modelPMID 15483670Read ↗

Gene Therapy to Modulate Alpha-Synuclein in SynucleinopathiesSemantic proximity Read ↗

Aggregate formation and toxicity by wild-type and R621C synphilin-1 in the nigrostriatal system of mice using adenoviral vectors.Semantic proximity Read ↗

Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques.Semantic proximity Read ↗

Rapid Induction of Dopaminergic Neuron Loss Accompanied by Lewy Body-Like Inclusions in A53T BAC-SNCA Transgenic MiceSemantic proximity Read ↗

A review of the advances, insights, and prospects of gene therapy for Alzheimer’s disease: A novel target for therapeutic medicineSemantic proximity Read ↗

Gene therapy: a viable therapeutic strategy for Parkinson’s disease?Semantic proximity Read ↗

Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectorsSemantic proximity Read ↗

Transgenic models of Alzheimer's disease: Better utilization of existing models through viral transgenesisSemantic proximity Read ↗

Gene therapy for neurodegenerative diseasesSemantic proximity Read ↗

Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectors.Semantic proximity Read ↗

Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype.Semantic proximity Read ↗

Gene-based therapies for neurodegenerative diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.